Log in to save to my catalogue

ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma

ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2a87bad4a8154cc9969bb2a939983550

ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma

About this item

Full title

ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma

Publisher

London: Nature Publishing Group UK

Journal title

NPJ precision oncology, 2024-03, Vol.8 (1), p.79-79, Article 79

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Glioblastoma (GBM), the most lethal primary brain cancer, exhibits intratumoral heterogeneity and molecular plasticity, posing challenges for effective treatment. Despite this, the regulatory mechanisms underlying such plasticity, particularly mesenchymal (MES) transition, remain poorly understood. In this study, we elucidate the role of the RNA-bi...

Alternative Titles

Full title

ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2a87bad4a8154cc9969bb2a939983550

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2a87bad4a8154cc9969bb2a939983550

Other Identifiers

ISSN

2397-768X

E-ISSN

2397-768X

DOI

10.1038/s41698-024-00566-1

How to access this item